Drug Shortage Report for JAMP DARIFENACIN
Report ID | 223959 |
Drug Identification Number | 02491877 |
Brand name | JAMP DARIFENACIN |
Common or Proper name | Darifenacin Extended Release Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DARIFENACIN |
Strength(s) | 15MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-03-29 |
Estimated end date | 2024-04-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-03-30 | French | Compare |
v1 | 2024-03-30 | English | Compare |
Showing 1 to 2 of 2